Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Evaluation of the safety and tolerability of a 20 mg once daily dose of memantine compared
with 10 mg given twice daily in patients with dementia of Alzheimer's type and MMSE range
5-18.